Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility, safety, and efficacy study of cardiac resynchronization therapy and intracoronary autologous bone marrow mononuclear cell transplantation after acute myocardial infarction
2009-013683-39Phase 2Completed
- Sponsor
- Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
- Start
- Jul 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous bone marrow-derived mononuclear cell in myocardial infarction (MI) (3 arms), sponsored by Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón. Primary endpoint: Safety and feasibility. Started Jul 2009; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2009-013683-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013683-39.